|
Hospital management of clinically unstable mild preeclampsia at the secondary level of care Please also refer to Figure 5. |
||||
| Mother |
Foetus |
|||
|
|
||||
| Monitoring: The patient must be hospitalised. |
||||
|
|
||||
| Clinical |
Exams as often as needed |
Clinical |
Exams as often as needed |
|
|
|
||||
| Blood pressure Weight Look for CNS, renal, cardiovascular or gastrointestinal symptoms at every visit |
Blood count (including platelet count) Urinalysis (proteinuria) every 24 hours or Dipstick every eight hours Liver Function Tests (Bilirrubin, AST, ALT) |
Foetal movements Foetal cardiac rate |
Cardiotocography: No-stress testing Ultrasonography to measure foetal growth and status of the placenta (site where the placenta is inserted and maturity) and amniotic fluid volume |
|
|
|
||||
| Treatment |
Treatment |
|||
|
|
||||
| Bed rest |
Anti-hypertensives (controversial) Methyldopa Nifedipine Hydralazine |
Anticonvulsants: Magnesium sulphate |
Induction of pulmonary maturity using dexamethasone or betamethasone in patients with gestational age less than 34 weeks. |
|
Perez-Cuevas et al. BMC Pregnancy and Childbirth 2003 3:6 doi:10.1186/1471-2393-3-6 |
||||